We hope this approval supports increasing access to obesity care in the UK. The pills, which contain semaglutide, are now approved for adults who are obese (BMI of 30 or above) or overweight (BMI of 27-30) and have at least one weight-related health condition
Media description (scene 11): A series of steps show a sneaker, bread with down arrow, a barbell and a scale, as Jason and dietitian make progress up the steps
10.1007/s11154-014-9289-5 101 ShawC.MortimerP.JuddP
The studies include one conducted under the auspices of the National Institute on Aging, one of the National Institutes of Health, published in the peer-reviewed journal Aging Cell in 2016
For many people, especially those without insurance coverage for weight loss medications, brand-name drugs are simply not accessible